Summary
Plasma exchange has been used for therapy in eight patients with the Guillain-Barré syndrome. All patients were severely ill. They became tetraplegic and showed cranial nerve involvement. Five patients received assisted respiration, but the others were also at risk of ventilatory insufficiency. Recovery was abrupt in all cases after the first plasma exchanges. Improvement was more marked when plasmapheresis was done on three successive days with plasma exchanges of 2.0–3.01 each in the initial progressive stage of the disease. A considerable advantage of this therapy is the avoidance of continued artificial respiration and nutrition, which both carry the risk of further complications.
Zusammenfassung
Die Wirksamkeit einer Plasmaaustausch-Behandlung wurde bei 8 Patienten mit einem Guillain-Barré-Syndrom geprüft. Alle Patienten hatten einen schweren Krankheitsverlauf gezeigt, mit schlaffen Tetraparesen und multiplem Hirnnervenbefall. Fünf Patienten mußten assistiert beatmet werden. Auch bei den anderen Patienten zeigten sich Hinweise für eine drohende respiratorische Insuffizienz. Nach den ersten Plasmapheresebehandlungen konnte eine abrupt einsetzende und deutliche Besserung der Ausfälle beobachtet werden. Die klinische Besserung verlief besonders eindrücklich, wenn der Plasmaaustausch an drei aufeinanderfolgenden Tagen mit einer Austauschmenge von jeweils 2,0–3,01 und in der initialen progressiven Phase der Erkrankung erfolgte. Ein großer Vorteil dieser Therapie dürfte in der Vermeidung langzeitiger künstlicher Beatmung und Ernährung und den damit verbundenen Komplikationen liegen.
Similar content being viewed by others
References
Abramsky O, Webb C, Teitelbaum D, Arnon DR (1975) Cell-mediated immunity to neural antigens in ideopathic polyneuritis and myeloradiculitis. Neurology 25:1154–1159
Arnason BG, Winkler GF, Hadler NM (1969) Cell-mediated demyelinization of peripheral nerve in tissue culture. Lab Invest 21:1–10
Asbury AK, Arnason BG, Adams RD (1969) The inflammatory lesion in idiopathic neuritis. Its role in pathogenesis. Medicine 48:173–215
Åström KE, Waksman BH (1962) The passive transfer of allergic encephalomyelitis and neuritis with living lymphoid cells. J Pathol Bact 83:89–106
Åström KE, Webster H, Arnason BG (1968) The initial lesion in experimental allergic neuritis (EAN). A phase and electron microscope study. J Exp Med 128:469–495
Behan PO, Behan WMH, Feldman RG, Kies MW (1972) Cell-mediated hypersensitivity to neural antigens. Arch Neurol 27:145–152
Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C (1978) Treatment of acute polyneuropathy by plasma exchange. Lancet 2:1100
Carpenter S (1972) An ultrastructural study of an acute fatal case of the Guillain-Barré syndrome. J neurol Sci 15:125–140
Cook SD, Dowling PC, Whitaker JN (1970) The Guillain-Barré syndrome: Relationship of circulating immunocytes to disease activity. Arch Neurol 22:470–474
Cook SD, Dowling PC, Murray MR, Whitaker JN (1971) Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 24:136–144
Cummings JF, Haas DC (1967) Coon hound paralysis. An acute idiopathic polyradiculoneuritis in dogs resembling the Landry-Guillain-Barré syndrome. J neurol Sci 4:51–81
Drachmann DA, Paterson PY, Berlin BS, Rogusta J (1970) Immunsuppression and the Guillain-Barré syndrome. Arch Neurol 23:385–393
Fowler H, Vulpe M, Marks G, Egolf C, Dau PC (1979) Recovery from chronic progressive polyneuropathy after treatment with plasma exchange and cyclophosphamide. Lancet 2:1193
Goodall JAD, Kosmidis JC, Geddes AM (1974) Effect of corticosteroids on course of Guillain-Barré syndrome. Lancet 1:524–526
Graveson GS (1957) Acute polyneuritis treated with cortisone. Lancet 1:340–343
Guillain G, Barré JA, Strohl A (1916) Sur un syndrome de radiculonévrite avec hyperalbuminase du liquide céphalo-rachidien sans réaction cellulaire: Remarques sur les caractères cliniques et graphiques des réflexes tendineux. Bull Méd Hôp Paris 40:1462–1470
Haymaker W, Kernohan JW (1949) The Landry-Guillain-Barré syndrome. Medicine 28:59–141
Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial of prednisolone in acute polyneuropathy. Lancet 2:750–753
Jackson RH, Miller H, Schapira K (1957) Polyradiculitis (Landry-Guillain-Barré syndrome). Treatment with cortisone and corticotrophin. Br med J 1:480–484
King EG, Jacobs H (1971) “Complications” of the Landry-Guillain-Barré syndrome. C.M.A.J. 104:393–398
Marshall J (1963) The Landry-Guillain-Barré syndrome. Brain 86:55–66
Masucci EF, Kurtze JF (1971) Diagnostic criteria for the Guillain-Barré syndrome. An analysis of 50 cases. J neurol Sci 13:483–501
Mayr U, Rumpl E, Hackl JM, Gerstenbrand F (1980) Treatment of Guillain-Barré syndrome by plasma exchange. International Symposion on Plasma Exchange Therapy, Wiesbaden, April, 15/16
Melnick SC (1963) Thirty eight cases of the Guillain-Barré syndrome. An immunologic study. Br med J 1:368–373
McIntyre HD, Krouse H (1949) Guillain-Barré syndrome complicating antirabies inoculation. Arch Neurol Psychiat 62:802–808
Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG (1978) Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigations by plasma exchange. Neurology 28:266–272
Reuther P, Wiebecke D, Hertel G, Böske A, Mertens HG (1979) Plasmapheresebehandlung bei Myasthenia gravis. Dtsch med Wschr 104:1806–1810
Rocklin RE, Sheremata WA, Feldman RG, Kies MW, David JR (1971) The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med 284:803–808
Ross J (1964) Über Autosensibilisierungsvorgänge bei entzündlichen Erkrankungen des Nervensystems. Klin Wschr 11:514–518
Samtleben W, Besinger UA, Toyka KV, Fateh-Moghadam A, Brehm G, Gurland HJ (1980) Plasma-separation in myasthenia gravis. A new method of rapid plasma exchange. Klin Wschr 58:47–49
Sheremata W, Colby S, Lusky G, Cosgrove JBR (1975) Cellular hypersensitization to peripheral nervous antigens in the Guillain-Barré syndrome. Neurology 25:833–839
Swick HM, McQuillen MP (1976) The use of steroids in the treatment of idiopathic polyneuritis. Neurology 26:205–212
Toyka KV, Becker T, Fateh-Moghadam A, Besinger UA, Brehm G, Neumeier D, Heininger K, Birnberger KL (1979) Die Bedeutung der Bestimmung von Antikörpern gegen Acetylcholinreceptoren in der Diagnostik der Myasthenia gravis. Klin Wschr 57:937–942
Tse KS, Arbesman CE, Tomasi TB (1971) Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. Clin Exp Immunol 8:881–887
Wisniewski H, Terry RD, Whitaker JN, Cook D, Dowling PC (1969) Landry-Guillain-Barré syndrome. A primary demyelinating disease. Arch Neurol 21:269–276
Author information
Authors and Affiliations
Additional information
Parts of the paper were presented at the International Symposion on Plasma Exchange Therapy, Wiesbaden, April 15/16, 1980 [23]
Rights and permissions
About this article
Cite this article
Rumpl, E., Mayr, U., Gerstenbrand, F. et al. Treatment of Guillain-Barré syndrome by plasma exchange. J Neurol 225, 207–217 (1981). https://doi.org/10.1007/BF00313750
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00313750